These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27370)

  • 21. Effects of SD/1601 on tolerance to exercise in patients with angina.
    Maggi A; Mariani G; Tettamanti R; Tallone G
    G Ital Cardiol; 1975; 5(1):142-8. PubMed ID: 235477
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
    Nordenfelt I; Olsson L; Persson S
    Eur J Clin Pharmacol; 1974; 7(3):157-62. PubMed ID: 4152812
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
    Roy P; Day L; Sowton E
    Br Med J; 1975 Jul; 3(5977):195-7. PubMed ID: 238716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new water-soluble, selective beta-blocker with intrinsic sympathomimetic activity (ICI 141.292) in angina pectoris.
    Erikssen J; Rollag A; Otterstad JE
    Acta Med Scand; 1988; 223(1):35-43. PubMed ID: 2894747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.
    Svendsen TL; Hartling O; Trap-Jensen J
    Eur J Clin Pharmacol; 1979 May; 15(4):223-8. PubMed ID: 38968
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of practolol on angina pectoris induced by atrial pacing.
    Gavrilescu S; Streian C; Pop T
    Cor Vasa; 1972; 14(4):259-64. PubMed ID: 4146675
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 31. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
    Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB
    Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
    Vandenbosch H; Piessens J; De Geest H
    Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of atenolol on ventilatory and cardiac function in asthma.
    Vilsvik JS; Schaanning J
    Br Med J; 1976 Aug; 2(6033):453-5. PubMed ID: 8188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
    Ekelund LG; Olsson AG; Orö L; Rössner S
    Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
    Sandler G; Clayton GA
    Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
    Adolfsson L; Areskog NH; Furberg C; Johnsson G
    Eur J Clin Pharmacol; 1974; 7(2):111-8. PubMed ID: 4152864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.